PA
JUNO

Profund Advisors’s Juno Therapeutics, Inc. JUNO Stock Holding History

Profund Advisors’s Portfolio JUNO Stock Details JUNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-31,805
Closed -$1.45M – 1526
2017
Q4 		$1.45M Sell
31,805
-1,640
-5% -$81.8K 0.06% 315
2017
Q3 		$1.5M Buy
33,445
+4,344
+15% +$148K 0.06% 287
2017
Q2 		$870K Sell
29,101
-1,987
-6% -$49K 0.04% 453
2017
Q1 		$690K Sell
31,088
-2,586
-8% -$55.5K 0.03% 646
2016
Q4 		$635K Sell
33,674
-5,340
-14% -$131K 0.03% 744
2016
Q3 		$1.17M Sell
39,014
-863
-2% -$26.8K 0.06% 326
2016
Q2 		$1.53M Buy
39,877
+148
+0.4% +$6.14K 0.07% 231
2016
Q1 		$1.51M Sell
39,729
-9,687
-20% -$338K 0.08% 215
2015
Q4 		$2.17M Sell
49,416
-340
-0.7% -$16.9K 0.1% 143
2015
Q3 		$2.02M Buy
+49,756
New +$2.18M 0.12% 132

Other funds holding JUNO

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Profund Advisors's JUNO Position: Q1 2018 in Review

Profund Advisors sold out of Juno Therapeutics, Inc. (JUNO) in Q1 2018, closing a stake of 31,805 shares — an estimated $1.45M sold.

Profund Advisors first reported a position in JUNO in Q3 2015 and held it in 10 quarters. The position peaked at $2.17M in Q4 2015. 2 funds tracked by Wall St. Rank hold JUNO as of Q1 2018.

  • Profund Advisors reported no remaining Juno Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
  • Profund Advisors sold 31,805 Juno Therapeutics, Inc. shares in Q1 2018, an estimated $1.45M.
  • Profund Advisors first reported a position in Juno Therapeutics, Inc. in Q3 2015 and held it in 10 quarters.
  • Profund Advisors's Juno Therapeutics, Inc. position peaked at $2.17M in Q4 2015.
  • 2 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q1 2018.

Based on Profund Advisors's 13F filing for Q1 2018, filed 14 May 2018.